PubMed Health⌕ Search

Biomedical subjects

G A Baker

Publications and source records attributed to G A Baker.

78 records · Page 5Linked to original sources
PubMed1977

Effect of psychotropic agents upon the blastogenic response of human t-lymphocytes.

Antischizophrenic agents, phenothiazine and nonphenothiazine, inhibit the transformation of the T-lymphocyte in vitro. This inhibition occurs only in the early event and is neither competitive with dopamine, nor appears to involve Na+/K+ adenosine triphosphatase. RNA synthesis is more sensitive to the inhibitory effect than DNA or protein synthesis. This leads to the conclusion that chlorpromazine may act by inhibiting the synthesis of newly formed RNA, and subsequently, transformation, rather than by alteration of the cell membrane.

Chlorpromazine↗
PubMed1976

Significance of radiocontaminants in 123I for dosimetry and scintillation camera imaging.

Estimates of absorbed radiation dose and qualitative assessments of image resolution were compared for pure 131I and for 123I produced by the 122Te(d,n), 124Te(p,2n), and 127I(p,5n) 123Xe reactions. A substantial reduction in radiation dose is indicated when 123I replaces 131I, in spite of the radiocontaminants typically present 30-35 hr after the production of 123I by any of these methods. Only a marginal further reduction in radiation dose was noted with use of the most "pure" 123I as opposed to the least "pure" 123I. Comparable scintillation camera resolution was obtained for all 123I preparations at 30-35 hr after bombardment when the medium-energy and pinhole collimators were used. However, the radiocontaminants in the 123I produced from tellurium affected image resolution when the low-energy collimator was used.

Iodine Radioisotopes↗
PubMedDate not supplied

Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy.

We have been involved in developing a health-related quality-of-life model for use as an outcome measure in epilepsy. As part of the further development of this model, we have developed a measure of life fulfillment. This scale is based on methods previously described by Krupinski in 1980. The value of Krupinski's approach is the opportunity for patients to weight the numerous aspects of their quality of life and assess the discrepancy between their actual and desired circumstances. The life fulfillment scale has been shown to be reliable (alpha = 0.7) and valid. The scale is currently being applied to several clinical studies in epilepsy. We believe that the scale provides a valuable contribution to our health-related quality-of-life model.

Adolescent↗